ASDA Move "Threat To Pharmacies"

23 June 1996

UK supermarket ASDA's continued attack on resale price maintenance on over-the-counter health products (Marketletters passim) threatens the livelihood of many independent community pharmacists who will not be able to compete in the price was which will inevitably follow, according to the Community Pharmacy Action Group.

This will mean many community pharmacists no longer stocking many medicines, says the CPAG. They will eventually have to close, forcing consumers to travel longer distances for their medicines and advice, and to have their prescriptions dispensed. The CPAG says it assumes that ASDA's attacks on RPM have been a way of publicizing its new line of cut-price health products, and hopes that "having manipulated the maximum publicity for their own launch, they will now leave the RPM issue to the Office of Fair Trading."

The CPAG is fighting to keep RPM, and is supported by the Royal Pharmaceutical Society of Great Britain, the National Pharmaceutical Association and the Proprietary Association of Great Britain, among other groups.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight